3.9 Letter

Rituximab treatment of post-COVID-19 development of acute-onset chronic inflammatory demyelinating polyneuropathy

Journal

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE
Volume 85, Issue 4, Pages 336-337

Publisher

CZECH MEDICAL SOC
DOI: 10.48095/cccsnn2022336

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available